Elevated plasma Bv8/PROK2 levels correlated with poor overall survival patients by suppressing these tumor-infiltrating neutrophils and the related angiogenic processes, restoring sensitivity to anti-VEGF therapies (165). The gene discussed is VEGFA; the disease is neoplasm.